Safe and Effective Bridging to Ciltacabtagene Autoleucel Using Bispecific T-cell Engagers in relapsed/refractory Multiple Myeloma Among an Urban Underserved Population
Fields of Study & Subjects
Multiple Myeloma Research and Treatments
CAR-T cell therapy research
Protein Degradation and Inhibitors
Publication details
- Journal / source
- Transplantation and Cellular Therapy
- Volume
- 32
- Issue
- 2
- Pages
- S431–S431
- Publication date
- 1 February 2026
- Language
- EN